Method for producing a novel melanoidin with antibacterial activity and its application

By producing melanoidin through a Maillard reaction with xylose and phenylalanine or proline, compounds with high antibacterial activity are created, addressing the limitations of current preservatives and providing a safe, efficient food preservation solution.

JP7594329B2Active Publication Date: 2024-12-04HOKKAIDO UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023554537
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-10-19
Filing Date
2022-10-11
Publication Date
2024-12-04
Estimated Expiration
2042-10-11

AI Technical Summary

Technical Problem

Existing antibacterial substances in food preservation, such as nisin, exhibit limited activity against specific bacteria and require complex production processes, while the antibacterial properties of melanoidins have not been comprehensively explored through combinations of reducing sugars and amino acids.

Method used

Production of melanoidin through a Maillard reaction using xylose and phenylalanine or proline to create compounds like 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid and 3,8-dihydroxy-2-methylchromone, which exhibit high antibacterial activity against bacteria like Listeria monocytogenes, Brevibacillus brevis, and Salmonella Typhimurium.

Benefits of technology

The produced melanoidin demonstrates antibacterial activity equivalent to or superior to existing preservatives, is safe for food use, and can be easily manufactured, offering a versatile and effective alternative for food preservation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007594329000012
    Figure 0007594329000012
  • Figure 0007594329000013
    Figure 0007594329000013
  • Figure 0007594329000014
    Figure 0007594329000014
Patent Text Reader

Abstract

Provided are: a method for producing an antimicrobial composition, said method comprising heating a reducing sugar selected from xylose and ribose and an amino acid selected from phenylalanine and proline to produce a melanoidin and blending the melanoidin as an active ingredient; an antimicrobial composition that comprises a melanoidin produced from xylose or ribose and phenylalanine as reaction substrates and / or a melanoidin produced from xylose or ribose and proline as reaction substrates; etc.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a novel method for producing melanoidin and an antibacterial agent containing melanoidin. [Background technology]

[0002] In order to live a safer diet, it is necessary to prevent the proliferation of bacteria in food that cause spoilage and food poisoning. In addition to sterilization by heating during the cooking process, food pH and water activity are adjusted, refrigerated or frozen storage is performed, and preservatives and shelf-life extenders are added to suppress the proliferation of bacteria that have invaded food after cooking. Focusing on preservatives and shelf-life extenders, sodium benzoate, potassium sorbate, sodium nitrite, nisin, etc. are currently used in a wide range of foods. Among them, nisin, which is produced from lactic acid bacteria, is used in many foods around the world because it has a wide range of antibacterial activity at a low dose. However, these preservatives and shelf-life extenders each exhibit antibacterial activity against different bacterial species, so new antibacterial substances are always required.

[0003] On the other hand, the antibacterial properties of melanoidins were suggested as early as the 1950s, and since then, research has been conducted on the antibacterial activity of various melanoidins, such as melanoidins contained in coffee, beer, straw wine, etc., and model melanoidins created from reducing sugars and amino acids (Non-Patent Documents 1 and 2). Melanoidins are a general term for the products of the Maillard reaction that occurs between the amino group of an amino acid, peptide, or protein and the carbonyl group of a reducing sugar. The Maillard reaction is a chemical reaction that is mainly seen in food, and is a series of polymerization reactions that use carbonyl compounds such as reducing sugars and amines such as amino acids as reaction substrates, through processes such as condensation, dehydration, and polymerization by heat, to produce melanoidin, a brown polymer, as the final product. The produced polymer, melanoidin, contains aroma substances inside and is known as a substance that affects the flavor of food, but its exact structure and composition are still unknown, and research on them is still ongoing.

[0004] However, there are a huge number of types of reducing sugars and amino acids, which are the reaction substrates for the Maillard reaction, and the number of combinations of the two is also huge. Therefore, changing the combination of reaction substrates will change the presence or absence and degree of antibacterial activity of the melanoidins produced. However, there have been no reports to date of the comprehensive combination of various reducing sugars and amino acids to produce melanoidins with antibacterial activity. [Prior art documents] [Non-patent literature]

[0005] [Non-Patent Document 1] Food Chemistry, Volume 111, Issue 4, 15 December 2008, pages 1069-1074 [Non-Patent Document 2] Biomedicines 2018, 6(3), 83; doi: 10.3390 / biomedicines6030083 Summary of the Invention [Problem to be solved by the invention]

[0006] In the present invention, we focused on the antibacterial activity of melanoidins, which are products of the Maillard reaction, and aimed to discover new melanoidins with antibacterial activity by comprehensively combining various reducing sugars and amino acids to produce melanoidins, searching for melanoidins with antibacterial activity, and establishing a reaction system. [Means for solving the problem]

[0007] As a result of intensive research to solve the above problems, the present inventors have found that melanoidin having antibacterial activity is produced by the Maillard reaction of xylose, an aldose of pentose, with phenylalanine or proline. Furthermore, the structure of one of the compounds contained in the obtained melanoidin has been identified. Thus, the present invention has been completed.

[0008] The present invention provides the following aspects. [1] Producing melanoidin by heating a reducing sugar selected from xylose or ribose and an amino acid selected from phenylalanine or proline; and The melanoidin is blended as an active ingredient. A method for producing an antimicrobial composition comprising: [2] The method according to [1] above, which comprises reacting xylose with phenylalanine, and the produced melanoidin comprises 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid; [3] The method according to [1] above, which comprises reacting xylose with proline, and the produced melanoidin comprises 3,8-dihydroxy-2-methylchromone; [4] The method according to any one of the above [1] to [3], wherein the antibacterial composition exhibits antibacterial activity against bacteria selected from the group consisting of Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium. [5] An antibacterial composition comprising a melanoidin produced from xylose or ribose and phenylalanine as reaction substrates, and / or a melanoidin produced from xylose or ribose and proline as reaction substrates; [6] The antibacterial composition according to [5] above, which exhibits antibacterial activity against bacteria selected from the group consisting of Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium. [7] Formula I: [ka] [Wherein, R1 to R 10 are independently a hydrogen atom or a C1-5 branched or straight chain saturated or unsaturated hydrocarbon group; and / or Formula III: [ka] [In the formula, R 11 Or R 16 are independently a hydrogen atom, a C1-5 branched or linear saturated or unsaturated hydrocarbon group, a hydroxyl group, a halogen atom, a sulfanyl group, an amino group, a nitro group, a carboxyl group, a sulfonic acid group, or an alkoxy group containing a C1-5 branched or linear saturated or unsaturated hydrocarbon group. or a salt thereof; [8] The antibacterial composition according to the above [7], wherein the compound represented by the formula is 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid and the compound represented by the formula III is 3,8-dihydroxy-2-methylchromone. [9] The antibacterial composition according to [8] or [7] above, which exhibits antibacterial activity against bacteria selected from the group consisting of Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium.

[10] A method for producing 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid, comprising carrying out a Maillard reaction using xylose and phenylalanine as reaction substrates;

[11] A method for producing 3,8-dihydroxy-2-methylchromone, comprising carrying out a Maillard reaction using xylose and proline as reaction substrates. Effect of the Invention

[0009] According to the method of the present invention, melanoidin having high antibacterial activity can be produced. The melanoidin thus produced is highly safe because it is produced from reducing sugars and amino acids, which are food materials, and can be safely used as an antibacterial agent in the fields of food and beverages, cosmetics, and pharmaceuticals. In addition, according to the present invention, there is provided a composition having high antibacterial activity, which contains a compound identified from the melanoidin produced by the method of the present invention.

[0010] Furthermore, the antibacterial composition of the present invention exhibits antibacterial activity equal to or greater than that of existing preservatives used in the food industry, such as nisin, sodium benzoate, and potassium sorbate. Furthermore, the antibacterial composition of the present invention can be produced simply by heating a solution in which reducing sugars and amino acids, which are reaction substrates, are dissolved, and therefore is advantageous in terms of productivity and reproducibility, and can be produced and used more easily. [Brief description of the drawings]

[0011] [Figure 1] The figure shows the effect of differences in reaction substrates (reducing sugars and amino acids) on the growth inhibitory effect of the produced melanoidins on L. monocytogenes at 25°C. [Diagram 2] The growth inhibitory effect of two types of melanoidins on Brevibacillus brevis at 25°C is shown. In the figure, ◯ indicates melanoidin produced from a combination of xylose and phenylalanine (melanoidin Xylose-Phe), × indicates melanoidin produced from a combination of xylose and proline (melanoidin Xylose-Pro), and △ indicates no melanoidin added (no addition). [Diagram 3] The bacterial growth inhibitory effect of two types of melanoidins on Bacillus cereus at 25°C is shown. In the figure, ○: melanoidin Xylose-Phe, ×: melanoidin Xylose-Pro, △: no addition. [Figure 4] The growth inhibitory effect of two types of melanoidins on Salmonella Typhimurium at 25°C is shown. In the figure, ○ indicates melanoidin Xylose-Phe, × indicates melanoidin Xylose-Pro, and △ indicates no addition. [Diagram 5] The figure shows a comparison of the growth inhibitory effects of two types of melanoidins and nisin against Listeria monocytogenes at 25°C. In the figure, ○: melanoidin Xylose-Phe, ×: melanoidin Xylose-Pro, ◇: nisin 250 IU / mL, □: nisin 350 IU / mL, ▽: nisin 400 IU / mL, △: no additive. [Figure 6] The effect of various additives on the change in logarithmic viable cell count of Bacillus cereus in beef bowls (at 25°C for 3 days) is shown. [Figure 7A] The antibacterial activity of sample A against Bacillus cereus at each concentration is shown. In the figure, ●: control, ▼: 4500 ppm, ■: 2250 ppm, ×: 1124 ppm. The horizontal axis indicates the incubation period (days). The vertical axis indicates the viable cell count. [Figure 7B] The antibacterial activity of sample B against Bacillus cereus at each concentration is shown. In the figure, ●: control, ▼: 4500 ppm, ■: 2250 ppm, ×: 1124 ppm. The horizontal axis indicates the incubation period (days). The vertical axis indicates the viable cell count. [Figure 8] The figure shows the antibacterial activity of the substance isolated from melanoidin. In the figure, ●: control, ▼: solution of isolated substance, ■: DMSO. × indicates the detection limit (<10 CFU / mL). The horizontal axis indicates the incubation period (days). The vertical axis indicates the viable cell count. [Figure 9] Chemical structures of antibacterial compounds contained in sample A (A) and key COSY and HMBC correlations (B) are shown. [Figure 10] The chemical structures of the antibacterial compounds (A) and the key COSY and HMBC correlations (B) are shown. [Figure 11] The antibacterial activity of compounds isolated from Maillard reaction products is shown. In the figure, ●: control, ▼: 0.25 mmol / L, ■: 0.5 mmol / L, ×: 1.0 mmol / L. ND indicates the detection limit. The horizontal axis indicates the incubation period (days). The vertical axis indicates the viable cell count. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] 1.Melanoidin manufacturing method The present invention provides a method for producing melanoidin, which comprises subjecting a reducing sugar selected from xylose or ribose and an amino acid selected from phenylalanine or proline as reaction substrates to a Maillard reaction.

[0013] As the reducing sugar of the reaction substrate of the Maillard reaction, xylose and ribose, which are pentose aldoses, are selected. The reducing sugar may be either D- or L-form. As the amino acid of the reaction substrate of the Maillard reaction, phenylalanine and proline are selected. The amino acid may be either D- or L-form. The reducing sugar and amino acid may be derived from a natural product or may be obtained by chemical synthesis. The amount of the reducing sugar and amino acid to be subjected to the reaction is not particularly limited as long as melanoidin is produced, and can be appropriately determined by a person skilled in the art.

[0014] The Maillard reaction is carried out by subjecting the above-mentioned reducing sugar and amino acid as reaction substrates to a heat treatment. The reaction substrate is preferably subjected to a heat treatment as a solution dissolved in a solvent such as water, for example as an aqueous solution. Heating conditions such as temperature and time are not particularly limited as long as melanoidin is produced, and can be appropriately set by those skilled in the art. For example, since the reaction proceeds in a shorter time at a higher temperature, it is efficient to carry out the reaction at as high a temperature as possible. Although not limited thereto, the reaction may be carried out at about 100°C to about 130°C, preferably about 115°C to about 125°C, for example, for about 30 to 100 minutes, preferably about 50 to 80 minutes. For example, the reaction may be carried out under high pressure conditions using an autoclave or the like.

[0015] The melanoidin produced by the method of the present invention has antibacterial activity against bacteria that cause spoilage and food poisoning, particularly Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium. Furthermore, the melanoidin exhibits antibacterial activity equal to or greater than that of existing preservatives such as potassium sorbate, sodium benzoate, protamine (milt protein extract), calcium propionate, glycine, and nisin.

[0016] As used herein, "antibacterial activity" means activity that suppresses or inhibits the growth of bacteria, and includes bactericidal, sterilizing and bacteriostatic activity.

[0017] 2. Antibacterial composition The present invention provides an antibacterial composition containing melanoidin produced by the above-mentioned Maillard reaction as an active ingredient. The antibacterial composition may contain only melanoidin produced from one combination of one type of reducing sugar selected from xylose or ribose and one type of amino acid selected from phenylalanine or proline, or may contain two or more types of melanoidin produced from two or more combinations of reducing sugar selected from xylose or ribose and amino acid selected from phenylalanine or proline. For example, the antibacterial composition of the present invention contains melanoidin produced from xylose or ribose and phenylalanine as reaction substrates, and / or melanoidin produced from xylose or ribose and proline as reaction substrates.

[0018] The melanoidin contained in the antibacterial composition of the present invention may be in a state contained in the reaction liquid obtained after the above-mentioned Maillard reaction, or may be separated from the reaction liquid. The separation may be performed by a conventional method, for example, but is not limited to, various chromatographic methods.

[0019] In the present invention, the chemical structure of one of the compounds contained in the melanoidins produced from xylose and phenylalanine as reaction substrates has been determined. Thus, in a further aspect of the present invention, a compound represented by formula I: [ka] [Wherein, R1 to R 10 are independently a hydrogen atom or a C1-5 branched or straight chain saturated or unsaturated hydrocarbon group. or a salt thereof.

[0020] In the compound of formula I, preferably, at least one, more preferably at least two, more preferably at least three, and even more preferably at least four of R1 to R5 are hydrogen atoms, and preferably, R6 to R 10 At least one, more preferably at least two, more preferably at least three, and even more preferably at least four of these are hydrogen atoms.

[0021] In the present invention, the chemical structure of one compound among the above melanoidins produced from xylose and proline as reaction substrates has been determined. Thus, in a further aspect of the present invention, a compound represented by formula III: [ka] [In the formula, R 11 Or R 16 are independently a hydrogen atom, a C1-5 branched or straight chain saturated or unsaturated hydrocarbon group, a hydroxyl group (-OH), a halogen atom, a sulfanyl group (-SH), an amino group (-NH2), a nitro group (-NO2), a carboxyl group (-COOH), a sulfonic acid group (-SO3H), or an alkoxy group containing a C1-5 branched or straight chain saturated or unsaturated hydrocarbon group. or a salt thereof.

[0022] In one embodiment of the compound of formula III, R 11 Or R 16 is independently selected from a hydrogen atom, a C1-5 branched or straight chain saturated or unsaturated hydrocarbon group, or a hydroxyl group.

[0023] In the compound of formula III, preferably, R 13 Or R 16 At least one, more preferably at least two, and even more preferably at least three of these are hydrogen atoms.

[0024] Examples of C1-5 branched or straight chain saturated or unsaturated hydrocarbon groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, etc., and preferably C1-3 hydrocarbon groups. The above hydrocarbon groups may be substituted.

[0025] Examples of halogen atoms include fluorine, chlorine, bromine and iodine.

[0026] Examples of alkoxy groups containing a C1-5 branched or straight chain saturated or unsaturated hydrocarbon include, but are not limited to, methoxy, ethoxy, n-propyloxy, isopropyloxy, propenyloxy, propynyloxy, n-butyloxy, sec-butyloxy, isobutyloxy, tert-butyloxy, butenyloxy, butynyloxy, and the like, and preferably include alkoxy groups containing a C1-3 hydrocarbon group.

[0027] An example of the compound represented by formula I above is the compound represented by formula II below: [ka] Thus, the present invention further provides an antibacterial composition comprising 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid or a salt thereof.

[0028] An example of the compound represented by the above formula III is the compound represented by the following formula IV: [ka] Accordingly, the present invention further provides an antibacterial composition comprising 3,8-dihydroxy-2-methylchromone or a salt thereof.

[0029] The compound represented by the above formula I may be obtained by performing a Maillard reaction using xylose and phenylalanine as reaction substrates, isolating 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid from the obtained melanoidin, and purifying it as necessary, or by chemical synthesis. Isolation and purification of 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid from melanoidin may be performed by known methods, for example, various chromatographic methods can be used. The thus obtained 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid may be further converted into various compounds included in formula I by conventional methods. Chemical synthesis of the compound represented by formula I can be performed by known methods. For example, 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid may be synthesized according to the method described in Chemistry of Heterocyclic Compounds 2017, 53(5), 526-531.

[0030] The compound represented by the above formula III may be obtained by carrying out a Maillard reaction using xylose and proline as reaction substrates, isolating 3,8-dihydroxy-2-methylchromone from the obtained melanoidin, and purifying it as necessary, or by chemical synthesis. Isolation and purification of 3,8-dihydroxy-2-methylchromone from melanoidin may be carried out by a known method, for example, various chromatographic methods can be used. The 3,8-dihydroxy-2-methylchromone thus obtained may be further converted into various compounds included in formula III by a conventional method. Chemical synthesis of the compound represented by formula III may be carried out by a known method.

[0031] The compounds represented by the above formula I and formula III may be in the form of salts acceptable in the fields of food and beverages, cosmetics, or pharmaceuticals.Examples of salts include, but are not limited to, inorganic acid salts such as hydrochloride, sulfate, phosphate, hydrobromide, etc., organic acid salts such as acetate, fumarate, maleate, oxalate, citrate, methanesulfonate, etc., metal salts such as sodium salt, potassium salt, calcium salt, magnesium salt, zinc salt, silver salt, copper salt, etc., or salts with inorganic bases such as ammonium salt, salts with organic bases such as methylamine salt, triethylamine salt, triethanolamine salt, etc. Such salts can be prepared by methods known in the art.

[0032] The antibacterial composition of the present invention may be the melanoidin obtained by the above Maillard reaction, or the compound represented by formula I or formula III itself, or may contain other components other than these active ingredients. Such other components include, but are not limited to, water, alcohol, various buffer solutions, etc., and may be appropriately mixed according to the purpose of use of the antibacterial composition. The content of the above melanoidin or compound in the antibacterial composition can be appropriately determined by those skilled in the art and is not particularly limited.

[0033] The antimicrobial composition of the present invention may be in any form available in the fields of food, beverage, cosmetics, or pharmaceuticals. Examples of such forms include, but are not limited to, solid (e.g., powder), liquid, or freeze-dried forms.

[0034] The antibacterial composition of the present invention can be used, for example, as a preservative, shelf life enhancer, or antiseptic in the fields of food, beverage, cosmetics, or pharmaceuticals. The antibacterial composition of the present invention can be used by adding it to various food, beverage, cosmetics, or pharmaceuticals, and can also be used in combination with existing preservatives, shelf life enhancers, or antiseptics. In the present specification, "addition" also includes blending, spraying, coating, and immersion. Examples of food and beverages in which the antibacterial composition of the present invention is used include, but are not limited to, fresh vegetables and fruits, fresh fish, cooked foods such as lunch boxes and side dishes, various processed fish and meat products, processed vegetables and fruits, and beverages, and are particularly suitable for use in food and beverages that are eaten as is. Examples of cosmetics in which the antibacterial composition of the present invention is used include, but are not limited to, shampoos, rinses, lotions, creams, and the like. In particular, when the active ingredient of the antibacterial composition of the present invention is melanoidin or a compound derived from melanoidin, the active ingredient is derived from a food material, and therefore the antibacterial composition has a higher safety.

[0035] The antibacterial composition of the present invention has antibacterial activity against bacteria that cause spoilage and food poisoning, particularly Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium. Furthermore, the antibacterial composition of the present invention exhibits antibacterial activity equal to or greater than that of existing preservatives such as potassium sorbate, sodium benzoate, protamine (milt protein extract), calcium propionate, glycine, and nisin.

[0036] Therefore, in a further aspect, the present invention provides a method for inhibiting bacterial growth in food, beverage, cosmetic or pharmaceutical, comprising adding the antibacterial composition of the present invention to the food, beverage, cosmetic or pharmaceutical. Here, the inhibition of bacterial growth includes inhibition of bacterial growth, killing and sterilization. The amount of the antibacterial composition to be added is not particularly limited as long as it has a growth inhibitory effect, and can be appropriately determined by those skilled in the art. EXAMPLES

[0037] Example 1: Maillard reaction using various reaction substrates and evaluation of antibacterial activity of melanoidin (1) Test material Two types of reducing sugars, D-glucose and D-xylose, were used in the Maillard reaction, and 11 types of amino acids, L-alanine, L-arginine, L-glutamine, L-leucine, L-methionine, L-phenylalanine, L-proline, L-threonine, L-valine, L-serine, and L-tryptophan, were used.

[0038] The following bacteria were used for the antibacterial activity evaluation. Gram-positive bacteria were Bacillus cereus (ATCC10987), Brevibacillus brevis (NBRC100599), Lactobacillus fructivorans (NBRC13954), and Listeria monocytogenes (ATCC19111). Gram-negative bacteria were Escherichia coli (O157:H7, HIPH 12361), Salmonella Enteritidis (RIMD1933001), and Salmonella Typhimurium (ATCC29630). Enterobacteria were Enterococcus faecalis (ATCC47077), Escherichia coli (ATCC 25922), Lactobacillus brevis (JCM 1059), and Staphylococcus epidermidis (ATCC 12221). These bacteria were cultured in liquid medium and the resulting bacterial solution was used in the experiments.

[0039] (2) Production of melanoidin By changing the combination of reducing sugar and amino acid, 22 types of melanoidin were produced. Based on previous research, in order to compare the antibacterial activity at the same melanoidin concentration, the absorbance at 420 nm was used as an index of melanoidin concentration, and an absorbance of 3.5 ± 0.2 was defined as the melanoidin concentration used in this study. Reducing sugar and amino acid were dissolved in equimolar concentrations in phosphate buffer of pH 7.0 and heated at 121°C and 2 atm in an autoclave for 60 minutes. The molar concentration before heating was adjusted so that the melanoidin concentration after heating was the concentration mentioned above.

[0040] (3) Evaluation of antibacterial activity The antibacterial activity of the 22 types of melanoidins produced in (2) above against Listeria monocytogenes (hereinafter abbreviated as L. monocytogenes) was compared. For the evaluation, the change in optical density accompanying bacterial growth was measured. Tryptic Soy Broth liquid medium (100 μL) was added to each melanoidin (100 μL), and L. monocytogenes solution (10 5 ~10 6 CFU / mL) was added (20 μL) and cultured at 25°C. The optical density (absorbance at 595 nm) of each solution was measured every 30 minutes for 24 hours using a microplate reader (BIO-RAD). After measurement, the change in optical density after 24 hours of culture was calculated. The culture test was performed three independent experiments. A two-fold dilution of liquid medium (100 μL) was used as a control experiment.

[0041] The results of evaluating the antibacterial activity of melanoidins are shown in Figure 1. Among the 22 types of melanoidins used in this study, the reaction substrates with the highest growth inhibitory effect against L. monocytogenes were combinations of xylose and phenylalanine, and xylose and proline. Moreover, under all amino acid conditions, the growth of L. monocytogenes was more significantly inhibited by melanoidins produced using D-xylose than by D-glucose. The reason why the antibacterial activity of melanoidins changed depending on the reducing sugar used as the reaction substrate is thought to be due to the difference in reactivity of the Maillard reaction depending on the reducing sugar.

[0042] There are two possible reasons why melanoidin produced using phenylalanine or proline had the highest antibacterial activity. The first is the structure of the amino acid. The chelating effect on bacterial cell walls has been proposed as the mechanism of antibacterial activity of melanoidin, and it is generally known that chelates are stable with five- or six-membered ring structures. Therefore, the six-membered ring structure of phenylalanine and the five-membered ring structure of proline may affect melanoidin produced from these substrates. The second is the effect of peptides in melanoidin. It has been reported that melanoidin, which is a polymer, contains peptides in which amino acids are bonded by peptide bonds. In addition, some peptides rich in proline and peptides containing phenylalanine produced by microorganisms and insects have antibacterial activity, so it is possible that peptides produced in melanoidin produced from phenylalanine or proline have antibacterial activity. From the above, it is speculated that the antibacterial activity of melanoidin produced from the combination of xylose and phenylalanine, and xylose and proline was the highest.

[0043] (4) Identification of the antibacterial activity range Two types of melanoidins produced in (2) above (melanoidins produced using a combination of xylose and phenylalanine, and a combination of xylose and proline as reaction substrates; hereafter abbreviated as "Xylose-Phe melanoidin" and "Xylose-Pro melanoidin", respectively) were used to identify the bacteria for which they exhibit antibacterial activity. The following measurements were carried out on all bacteria cultured in (1) above. Tryptic Soy Broth liquid medium (500 μL each) was added to the two types of melanoidins (500 μL each), and the bacterial liquid (10 5 ~10 6 20 μL of each of the cultures was dispensed and cultured at 25° C. for 48 hours. During the culture period, samples were extracted at 12-hour intervals to measure the number of viable bacteria (colony forming unit: CFU / mL).

[0044] As a result, the above two types of melanoidins showed high antibacterial activity against Brevibacillus brevis in addition to L. monocytogenes, and the viable cell count continued to decrease for 48 hours (Figure 2). Furthermore, Xylose-Phe melanoidin showed particularly high antibacterial activity against Bacillus cereus, and Xylose-Pro melanoidin showed particularly high antibacterial activity against Salmonella Typhimurium (Figures 3 and 4). However, Xylose-Pro melanoidin only slightly increased the viable cell count against Bacillus cereus up to 24 hours after incubation at 25°C, and showed sufficient growth inhibition compared to when no melanoidin was added (Figure 3). Furthermore, Xylose-Phe melanoidin reduced the viable cell count against Salmonella Typhimurium up to 12 hours after incubation at 25°C, and maintained the viable cell count at the start of the experiment after 24 hours, showing sufficient growth inhibition (Figure 4). The reason why the two types of melanoidins showed different antibacterial activities is thought to be because, if we assume that peptides are produced within melanoidins as mentioned above, the antibacterial peptides produced are different.

[0045] The two types of melanoidins showed little or no antibacterial activity against other bacteria. In particular, the reason why melanoidins did not show strong antibacterial activity against the four types of intestinal bacteria and other lactic acid bacteria is thought to be because those bacteria are resistant to melanoidins. Humans have been producing and eating foods containing melanoidins since ancient times, so the intestinal flora living in the human intestine has been frequently exposed to melanoidins. Therefore, it is speculated that the intestinal flora has become resistant to melanoidins. The same can be said for L. fructivorans, which is not an intestinal bacterium. This bacterium can survive in tsukudani and reduced-salt soy sauce, and is said to be salt-resistant. However, since tsukudani and soy sauce are both foods that contain melanoidins, it is speculated that L. fructivorans has acquired melanoidin resistance like intestinal bacteria.

[0046] (5) Performance evaluation of melanoidin Two types of melanoidins (Xylose-Phe melanoidin and Xylose-Pro melanoidin) were used, and their antibacterial properties were compared with those of the existing preservative, nisin. Nisin solutions were prepared at 500, 700, or 800 IU / mL. Here, 1 IU (International Unit) represents 0.25 μg. As in (3) above, melanoidin and nisin solutions were mixed with Tryptic Soy Broth liquid medium, and L. monocytogenes (10 5 ~10 6 The viable cell count (CFU / mL) was measured at 12-hour intervals during the culture period.

[0047] The results of comparing the antibacterial activity of nisin and melanoidin against L. monocytogenes are shown in Figure 5. Under the nisin-added condition, a decrease in the number of viable bacteria was observed 12 hours after the addition of nisin, but a similar decrease in the number of viable bacteria was not observed under the melanoidin-added condition, and the number of viable bacteria remained almost constant throughout the 48-hour culture period. In addition, under the 250 IU / mL (domestic standard for Western confectionery, etc.) and 350 IU / mL nisin-added conditions, the number of viable bacteria increased after 12 hours, and at the time of measurement after 48 hours, the number of viable bacteria had increased to the same level as or even higher than under the melanoidin-added condition. These results showed that the antibacterial activity of the two types of melanoidin used in this study against L. monocytogenes was about 250 to 350 IU / mL for nisin, but that its growth inhibitory effect was sustained.

[0048] Example 2: Evaluation of antibacterial activity of melanoidin against food poisoning bacteria in food In this study, we focused on Bacillus cereus (hereafter referred to as B. cereus), a food poisoning bacterium that survives during heat processing, and clarified the bacterial growth inhibitory effect of melanoidin in foods after heat cooking by comparing it with existing preservatives.

[0049] 1. Experimental Method (1) Test bacteria and materials B. cereus isolated from processed foods was cultured in Tryptic Soy Broth liquid medium for 10 9 The bacterial solution was adjusted to CFU / mL. The target food was beef bowl, which is a concern for the survival of B. cereus during the stewing process, and the soup base was extracted from a beef bowl base that had been sterilized with a retort. The pH of the test soup was 5.6 and the water activity was 0.977.

[0050] (2) Preparation of melanoidin D-xylose and L-phenylalanine were prepared to a concentration of 40 mM each in a phosphate buffer solution of pH 7.0, and then mixed and heated in an autoclave at 121°C and 2 atm for 1 hour. After heating, the mixture was quickly cooled with cold water and pre-frozen at -30°C for 24 hours. The frozen sample was then placed in a vacuum freeze dryer and freeze-dried to prepare powdered melanoidin.

[0051] (3) Comparison of antibacterial activity 7.0 mg of the melanoidin powder prepared in (2) above and 100 μL of the B. cereus cell solution were added to 900 μL of the soup base for beef bowl retort food, and the mixture was cultured at 25°C for 3 days, with the viable cell count in the solution being measured every 24 hours. In order to compare the antibacterial activity of melanoidin with that of existing preservatives and shelf life enhancers, glycine, protamine (milt protein extract), calcium propionate, sodium benzoate, and potassium sorbate, which are currently commonly used as preservatives and shelf life enhancers, were prepared at the same additive concentrations as melanoidin, and the viable cell count in the B. cereus-containing solution was similarly measured. As a negative control, the viable cell count in the B. cereus-containing solution without any additives was measured.

[0052] (4) Statistical processing To evaluate the effects of various additives during the same storage period, differences in antibacterial activity among six additives, including melanoidin, were tested using Tukey's multiple comparison test.

[0053] 2. Results and Discussion The results are shown in Table 1 and Figure 6. As is clear from these results, the addition of melanoidin was able to suppress the growth of B. cereus in beef bowls stored at 25°C to below the initial bacterial count for at least three days. Compared to the bacterial counts when existing preservatives or shelf life enhancers were added, the bacterial counts when melanoidin was added were lower than when potassium sorbate was added, and slightly higher than when sodium benzoate was added (Figure 6). Furthermore, on the first and second days, the bacterial counts were the lowest when melanoidin was added (Table 1). In this study, experiments were performed using two different strains of B. cereus (ATCC 10987 and a strain isolated from a food manufacturing plant), and both strains showed similar results, confirming that melanoidin has antibacterial activity regardless of the strain.

[0054] Tukey's multiple comparison test of the number of bacteria in beef bowls stored at 25°C showed that there was no significant difference from the addition of sodium benzoate on the second day and from the addition of potassium sorbate on the third day, and therefore it can be said that the antibacterial activity of melanoidin is equal to or greater than that of sodium benzoate and potassium sorbate (Table 1). In other words, it was revealed that melanoidin, which can be prepared simply by heating amino acids and reducing sugars, has antibacterial activity equal to or greater than that of existing preservatives. Both sodium benzoate and potassium sorbate are strong preservatives whose amounts added to food are regulated by law. As the antibacterial activity of melanoidin is equal to or greater than that of these reagents, it was suggested that melanoidin could be used to develop new methods for preventing food poisoning and suppressing food spoilage using substances derived from food ingredients.

[0055] Table 1. Effect of various additives on the growth of Bacillus cereus in beef bowls at 25℃ [Table 1] The values ​​in the table show the logarithmic viable count of B. cereus as the average ± standard deviation (n = 3). Different letters indicate significant differences at the same measurement point (P < 0.05).

[0056] Example 3: Isolation of antibacterial compounds from Xylose-Phe melanoidin The types and amounts of melanoidin intermediates formed during the Maillard reaction are enormous, and their chemical structure depends on conditions such as processing speed and processing time, so they are considered to be a heterogeneous mixture of different partial structures, and their structure is uncertain. Therefore, the mechanism of the antibacterial activity of melanoidin has not yet been clarified. In this study, we repeatedly separated the components of melanoidin, a complex substance, using its scientific properties, selected a group of substances with antibacterial activity, and clarified the chemical structure that is the cause of the antibacterial activity of the selected group of substances.

[0057] I. Selection of substances with antibacterial activity 1. Experimental Method (1) Test bacteria and materials Bacillus cereus (ATCC 10987) was cultured in Tryptic Soy Agar medium (TSA) at 37°C for 24 hours, and then enriched in Tryptic Soy Broth liquid medium (TSB) at 37°C for an additional 24 hours. The bacterial suspension thus prepared was used in the following experiments.

[0058] (2) Preparation and isolation of melanoidins D-xylose and L-phenylalanine were prepared to a concentration of 40 mM each in a phosphate buffer solution of pH 7.0, then mixed and heated in an autoclave at 121°C for 1 hour to produce melanoidin. The produced melanoidin was separated using a separatory funnel, and the resulting ethyl acetate extract was further separated using silica gel chromatography to produce fractions. This fraction was subjected to thin layer chromatography (TLC) to obtain two marked fractions (sample A and sample B). The concentrations of these samples were adjusted to 4500 ppm, 2250 ppm, or 1124 ppm in the sample stock solution. The samples were prepared by concentrating once to remove the solvent, and then dissolving them in pure water.

[0059] (3) Antibacterial activity of the samples A sample stock solution was prepared by adding 100 μL of the Bacillus cereus solution prepared in (1) above to a mixture of 450 μL of the sample of each concentration prepared in (2) above and 450 μL of TSB, and the number of bacteria in the solution was measured every 24 hours. 100 μL of the diluted sample was applied to TSA, and after 24 hours of incubation at 37°C, the number of colonies (CFU) that appeared on the TSA was measured, which was the number of bacteria at each measurement time. For comparison, the same procedure was performed using a control in which 450 μL of the sample was replaced with 450 μL of peptone water.

[0060] 2. Results and Discussion The results of the antibacterial activity of isolated sample A and sample B at each concentration are shown in Figure 7A and Figure 7B, respectively. Sample A showed antibacterial activity at all concentrations, and the antibacterial activity was almost the same at 4500 ppm and 2250 ppm, indicating a fairly strong antibacterial activity (Figure 7A). Furthermore, the number of live bacteria continued to decrease even at 1124 ppm, indicating a certain degree of strong antibacterial activity. In contrast, sample B showed some antibacterial activity at 4500 ppm, but at other concentrations, the number of live bacteria was almost the same as when sample B was replaced with peptone water (control), and almost no antibacterial activity was observed (Figure 7B). From these results, it was found that the antibacterial activity of melanoidin is strongly influenced by substances in sample A. In addition, since the antibacterial activity of sample A at 4500 ppm and 2250 ppm was almost the same, it is possible that the antibacterial activity of sample A may reach its limit at a certain concentration or higher.

[0061] II. Isolation of antibacterial compounds 1. Experimental Method (1) Test bacteria and materials A frozen stock of Bacillus cereus (ATCC 10987) was spread onto Tryptic Soy Agar (TSA) medium using a platinum loop, and then cultured at 37°C for 24 hours. It was then cultured in Tryptic Soy Broth (TSB) liquid medium for another 24 hours, and then cultured at 10°C for 10 hours. 9 The bacterial solution thus prepared was used in the following experiments.

[0062] (2) Preparation and isolation of melanoidins D-xylose and L-phenylalanine were prepared to a concentration of 40 mM each in a pH 7.0 phosphate buffer solution, then mixed and heated in an autoclave at 121°C for 1 hour. The ethyl acetate extract of the produced melanoidin was extracted by column chromatography (solvent: 20% methanol: 80% chloroform) to obtain Sample A. Sample A was further subjected to column chromatography (solvent: 50% ethyl acetate: 50% toluene) to isolate the substance. This substance was dissolved in a mixed solvent of DMSO and pure water to prepare a solution (sample) for use in the following experiments.

[0063] (3) Bacteria count measurement A sample stock solution was prepared by adding 100 μL of the Bacillus cereus bacteria solution prepared in (1) above to a mixture of 450 μL of sample and 450 μL of TSB, and the number of bacteria in the solution was measured every 24 hours. 100 μL of the diluted sample stock solution was applied to an agar medium, and after 24 hours of incubation at 37 °C, the number of colonies (CFU) that appeared on the agar plate was measured and used as the number of bacteria at each measurement time. In addition, to confirm the antibacterial activity of DMSO, the same operation was performed with a mixture of DMSO and pure water adjusted to the same concentration as the isolated substance in (2) above in the sample stock solution, replacing 450 μL of the sample with DMSO. Furthermore, for comparison, a similar operation was performed with a mixture of 450 μL of sample and 450 μL of peptone water as a control.

[0064] 2. Results and Discussion The results are shown in Figure 8. The solution of the isolated substance showed a fairly strong antibacterial activity, but the mixed solution of DMSO and water showed no antibacterial activity, just like the control where DMSO was replaced with peptone water. This shows that the substance isolated from melanoidin shows antibacterial activity.

[0065] Example 4: Determination of Chemical Structures of Antibacterial Compounds from Xylose-Phe Melanoidin The compound isolated in Example 3 was subjected to various instrumental analyses to determine its chemical structure. As a result, a strong signal was observed at m / z 291.13 in FD-MS (Field Desorption-Mass Spectroscopy) analysis. The exact mass of this signal was m / z 291.1274, and the molecular formula was C 19 H 17 It was estimated to be NO2 (calculated mass 291.1259). 1 H-NMR, 13 The structure of the compound was determined by C-NMR, COSY, HSQC, and HMBC spectra, and its chemical structure was determined to be 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid (Figure 9A). 1 H-NMR and 13 The signals in the C-NMR spectrum are listed in Table 2, and the key COSY and HMBC correlations are shown in Figure 9B.

[0066] Table 2. Sample A 1 H-NMR and 13 C-NMR spectrum data [Table 2]

[0067] Example 5: Isolation of antibacterial compounds from Xylose-Pro melanoidin and determination of their chemical structures An antibacterial substance was isolated and purified from the Maillard reaction solution prepared from D-xylose and L-proline, which was found to have strong antibacterial activity in Example 1.

[0068] (1) Preparation of Maillard reaction mixture D-xylose and L-proline were dissolved in a phosphate buffer solution (500 mL) of pH 7.0 at a concentration of 40 mM each, and reacted at 121° C. for 1 hour in an autoclave to obtain a Maillard reaction solution.

[0069] (2) Isolation of Compounds The Maillard reaction solution prepared in (1) above was subjected to ethyl acetate extraction, and the resulting ethyl acetate layer was concentrated under reduced pressure and then purified using silica gel column chromatography (silica gel 45 g, MeOH:CHCl3=5:95). Among the obtained fractions, the fraction having strong antibacterial activity against Salmonella typhimurium ATCC 29630 was further purified using high performance liquid chromatography [column: YMC-Pack ODS-AM (5 μm, 300 × 10 mm); eluent: 50% (v / v) MeOH; flow rate: 1.8 mL / min] to obtain the compound (2.1 mg) as a brown oily substance.

[0070] (3) Compound structure determination The purified compound obtained in (2) above was subjected to various instrumental analyses to determine its chemical structure. As a result of FD-MS analysis, a strong signal was observed at m / z 192.0. The exact mass of this signal was m / z 192.0432, and the molecular formula was C 10 It was estimated to be H8O4 (calculated mass 192.0423). 1 H-NMR, 13 The structure of the compound was determined by C-NMR, COSY, HSQC, and HMBC spectra, and its chemical structure was determined to be 3,8-dihydroxy-2-methylchromone (Figure 10A). 1 H-NMR and 13 The signals in the C-NMR spectrum are listed in Table 3, and the key COSY and HMBC correlations are shown in Figure 10B.

[0071] Table 3. Compounds 1 H-NMR and 13 C-NMR spectrum data [Table 3]

[0072] (4) Antibacterial activity of the compound The purified compound obtained in (2) above was dissolved in methanol and diluted with sterile water to prepare a sample solution with a concentration of 0.25, 0.5, or 1.0 mmol / L in the sample stock solution. 450 μL of this sample solution was mixed with 450 μL of liquid medium (Tryptic Soy Broth, TSB), and 100 μL of Salmonella typhimurium (ATCC 29630) bacterial solution was added to prepare a sample stock solution. This sample stock solution was cultured at 25°C, and the initial bacterial count and the viable bacterial count in the sample after 1 day, 3 days, and 7 days of culture were measured. The viable bacterial count was evaluated as the number of colonies (Colony Forming Unit, CFU) that appeared after 24 hours of culture at 37°C by applying 100 μL of the diluted sample to an agar medium (Tryptic Soy Agar, TSA). For comparison, the same operation was performed as a control, except that 450 μL of the sample solution was replaced with 450 μL of peptone water.

[0073] The results of antibacterial activity are shown in Figure 11. Among the samples used in this test, the 0.5mmol / L and 1.0mmol / L samples showed strong antibacterial activity. In the 0.5mmol / L and 1.0mmol / L samples, the number of live bacteria decreased to below the detection limit after 1 day, and no bacteria were detected even after 3 days, so it is believed that the bacteria were inactivated. In the 0.25mmol / L sample, no bacteria grew after 1 day, and even after 3 days, the increase in the number of live bacteria was suppressed to within one digit compared to the initial number. However, after 7 days, the number of live bacteria increased to the same level as the control. This revealed that even 0.25mmol / L showed a growth inhibitory effect for at least 3 days. [Industrial Applicability]

[0074] The antibacterial composition of the present invention and the melanoidin produced by the production method of the present invention can be safely used as a shelf life enhancer, preservative, antiseptic, etc. in the fields of foods and beverages, cosmetics, pharmaceuticals, etc.

Claims

1. Producing melanoidin by heating a reducing sugar selected from xylose or ribose and an amino acid selected from phenylalanine or proline to obtain a melanoidin having an absorbance at 420 nm of 3.5±0.2 or more; The melanoidin is blended as an active ingredient. A method for producing an antimicrobial composition comprising:

2. The method according to claim 1, wherein the melanoidin production process comprises heating a reducing sugar selected from xylose or ribose and an amino acid selected from phenylalanine or proline in a solution of pH 7.0 at 100°C to 130°C.

3. 2. The method of claim 1, comprising reacting xylose with phenylalanine, and wherein the melanoidin produced comprises 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid.

4. 2. The method of claim 1, comprising reacting xylose with proline, and wherein the melanoidins produced comprise 3,8-dihydroxy-2-methylchromone.

5. 5. The method of any one of claims 1 to 4, wherein the antimicrobial composition exhibits antimicrobial activity against a bacterium selected from the group consisting of Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium.

6. An antibacterial composition comprising a melanoidin produced from xylose or ribose and phenylalanine as reaction substrates and having an absorbance at 420 nm of 3.5±0.2 or more, and / or a melanoidin produced from xylose or ribose and proline as reaction substrates and having an absorbance at 420 nm of 3.5±0.2 or more.

7. The antibacterial composition according to claim 6, comprising a melanoidin produced from xylose or ribose and phenylalanine as reaction substrates by heating at 100°C to 130°C in a solution of pH 7.0, and / or a melanoidin produced from xylose or ribose and proline as reaction substrates by heating at 100°C to 130°C in a solution of pH 7.

0.

8. 8. The antibacterial composition of claim 6 or 7, which exhibits antibacterial activity against bacteria selected from the group consisting of Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium.

9. Formula I: 【Chemistry 1】 [In the formula, R 1 Or R 10 are independently a hydrogen atom or a C1-5 branched or straight chain saturated or unsaturated hydrocarbon group; and / or Formula III: 【Chemistry 2】 [In the formula, R 11 Or R 16 are independently a hydrogen atom, a C1-5 branched or linear saturated or unsaturated hydrocarbon group, a hydroxyl group, a halogen atom, a sulfanyl group, an amino group, a nitro group, or a sulfonic acid group. or a salt thereof.

10. 10. The antimicrobial composition of claim 9, wherein the compound represented by formula I is 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid and the compound represented by formula III is 3,8-dihydroxy-2-methylchromone.

11. 11. The antimicrobial composition of claim 9 or 10, which exhibits antimicrobial activity against a bacterium selected from the group consisting of Listeria monocytogenes, Brevibacillus brevis, Bacillus cereus, and Salmonella Typhimurium.

12. A method for producing 3-phenyl-2-(3-phenyl-1H-pyrrol-1-yl)propanoic acid, comprising carrying out a Maillard reaction using xylose and phenylalanine as reaction substrates.

13. A method for producing 3,8-dihydroxy-2-methylchromone, comprising carrying out a Maillard reaction using xylose and proline as reaction substrates.